Kynam Capital Management »

Caribou Biosciences shares owned by Kynam Capital Management

Quarter-by-quarter ownership of Caribou Biosciences (CRBU) shares owned by Kynam Capital Management from 13F filings

Historical chart of Kynam Capital Management investment in Caribou Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Caribou Biosciences held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caribou Biosciences by Kynam Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.7M 1.6M 1.64
2024-03-31 $5.5M 1.1M 5.14
2023-12-31 $6.1M 1.1M 5.73
2023-09-30 $5.1M 1.1M 4.78

More positions owned by Kynam Capital Management

Natera (NTRA)
Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Dynavax Technologies Corp Com New (DVAX)
Cogent Biosciences (COGT)
Insmed Com Par $.01 Call Option (INSM)
Vaxcyte (PCVX)
Vera Therapeutics Cl A (VERA)
BioCryst Pharmaceuticals (BCRX)
Protagonist Therapeutics (PTGX)
2seventy Bio Common Stock (TSVT)
Miragen Therapeutics (VRDN)
Wave Life Sciences SHS (WVE)

View all positions for Kynam Capital Management

Top funds holding Caribou Biosciences

BlackRock
Vanguard Group
Bank of America Corporation
Partner Fund Management
Dimensional Fund Advisors
Point72 Asset Management
Elmwood Wealth Management
Geode Capital Management
Kynam Capital Management
State Street Corporation
Renaissance Technologies
Goldman Sachs Group
Two Sigma Investments
Two Sigma Advisers
Schonfeld Strategic Advisors

View all funds holding Caribou Biosciences